Pfizer: one of the next big AI winners

Kirk Spano, a savvy analyst, dives into why Pfizer is poised to be a major player in the AI revolution, especially in cancer treatment. He shares compelling insights on utilizing cash-secured puts as a strategic trading method, highlighting Pfizer's strong market positioning. Spano also discusses advanced investment strategies and the shift in private equity towards AI and renewable energies. He emphasizes the critical importance of margin of safety in investing, using Pfizer's case to illustrate effective analysis and decision-making.